Noveris Health Sciences is trading at CA$1.27, up 5.8% today, continuing a highly volatile pattern observed over the past week.
- The upward move appears to be driven by speculative trading, as there are no fresh, price-specific headlines or catalysts identified for July 24, 2026.
- Recent corporate disclosures include a scheduled Annual General Meeting for September 4, 2026, and an April 2026 term sheet regarding a stem-cell acquisition.
- The stock has maintained a high-volatility profile following a previous regulatory trading halt in March 2026.